(Q41669033)

6 October 2017

title

Normalizing hematocrit in dialysis patients improves brain function (English)

1 reference

6 October 2017

0 references

Pickett JL

1

1 reference

6 October 2017

Theberge DC

2

1 reference

6 October 2017

Brown WS

3

1 reference

6 October 2017

Schweitzer SU

4

1 reference

6 October 2017

Nissenson AR

5

1 reference

6 October 2017

publication date

1 June 1999

1 reference

American Journal of Kidney Diseases

6 October 2017

published in

1 reference

6 October 2017

volume

33

1 reference

6 October 2017

issue

6

1 reference

6 October 2017

page(s)

1122-1130

1 reference

Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Improvement of brain function in hemodialysis patients treated with erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

rHuEPO treatment improves brain and cognitive function of anemic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Cognitive function, mood and P3 latency: effects of the amelioration of anemia in dialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

ELECTROENCEPHALOGRAPHIC EVALUATION OF UREMIA. WAVE FREQUENCY EVALUATIONS ON 40 UREMIC PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Quantitative indices of clinical uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Visual evoked potentials and long latency event-related potentials in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Temporal effects of hemodialysis on measures of neural efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Spatial analysis of evoked potentials in man--a review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Longitudinal P300 latency changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Haemoglobin--is more better?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

Target haematocrit during erythropoietin therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970150-2

7 January 2021

10.1016/S0272-6386(99)70150-2

Identifiers

DOI

1 reference

6 October 2017

1 reference